 Hoth Therapeutics Incs NASDAQ: HOTH development partner, Voltron Therapeutics Inc has announced positive data from its second set of preclinical animal testing of HaloVax Self-Assembling Vaccine SAV against COVID-19. The study investigated an updated construct to identify the best balance of immune responses to prevent the infection. 